Navigation Links
Technical Scrutiny: Thermo Fisher, Agilent Technologies, Laboratory Corp. of America, and PerkinElmer
Date:8/1/2013

LONDON, August 1, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

On Wednesday, July 31, 2013, shares in medical laboratory & research companies ended mostly lower even as the broader market ended on a mixed note. The major movers in the industry included Thermo Fisher Scientific Inc. (NYSE: TMO), Agilent Technologies Inc. (NYSE: A), Laboratory Corp. of America Holdings (NYSE: LH), and PerkinElmer Inc. (NYSE: PKI).  AAAResearchReports.com tracked TMO, A, LH, and PKI. These reports can be seen for free at:

http://www.aaaresearchreports.com/register/  

Shares in Thermo Fisher Scientific Inc. edged higher on Wednesday even as the broader market ended on a mixed note. The company's shares oscillated between $90.47 and $91.87 before finishing the day 0.70% higher at $91.11. A total of 1.78 million shares were traded, which is below the daily average volume of 1.99 million. The company's shares have advanced 7.66% in the last one month and 12.93% in the last three months as compared to a gain of 4.95% and 5.52% in the S&P 500 during the respective periods. Furthermore, the stock is currently trading near its 52-week high of $92.29. Download free research on TMO by signing up now at:

http://www.AAAResearchReports.com/TMO080113.pdf

Agilent Technologies Inc.'s stock moved lower on Wednesday, extending its losses for the week. The company's shares oscillated between $44.66 and $45.30 before closing the day 0.27% lower at $44.73. A total of 2.81 million shares were traded, which is below the daily average volume of 2.90 million. The company's shares have fallen by 1.91% in the last three trading sessions, underperforming the S&P 500 which has fallen 0.35%. Despite the pullback this week, the stock is currently trading near its 52-week high of $47.47. Register for today's free analysis on A at:

http://www.AAAResearchReports.com/A080113.pdf

Shares in Laboratory Corp. of America Holdings also edged lower on Wednesday, ending the session at $96.74, down 0.70% from the previous closing price. The company's shares oscillated between $96.49 and $97.75. A total of 1.03 million shares were traded, which is above the daily average volume of 806,788. The stock has fallen by 1.64% in the last three trading sessions, underperforming the S&P 500. A free report on LH can be accessed by registering at:

http://www.AAAResearchReports.com/LH080113.pdf  

PerkinElmer Inc.'s stock edged lower on Wednesday, finishing at $34.09, down 0.84% from its previous closing price. The company's shares fluctuated between $34.09 and $34.58. A total of 1.09 million shares were traded, which is above the daily average volume of 917,980. PerkinElmer's shares have advanced 4.89% in the last one month as compared to a gain of 4.95% in the S&P 500. Moreover, the stock is currently trading near its 52-week high of $35.86. Register with AAA Research Reports and download research on PKI for free at:

http://www.AAAResearchReports.com/PKI080113.pdf

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

http://AAAresearchreports.com

 


'/>"/>
SOURCE AAA Research Reports
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site
2. BC Technical Acquires NC Systems
3. Marken Expands Regulatory And Technical Excellence In Logistics
4. PDAs New Technical Report Portal is Now Open!
5. Cen-Med Enterprises, Leading Supplier to the Healthcare Industry, Debuts New Technical Services Division Dedicated to Repair and Maintenance of Analytical Instruments and Lab Storage Equipment
6. Scripps Research Institutes Richard A. Lerner Wins Prince of Asturias Award for Scientific and Technical Research
7. Amgen and Peregrine Under StockCall Scrutiny: Pharma Stocks Deal with Drug Developments and Patents
8. BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research
9. US HCG Injections Puts Top Vitamin Based Thermogenic Lipotropic Injections on Sale
10. What Will Thermo Fisher Scientific and Life Technologies $14 billion Merger hold for the Top Ten Suppliers of Synthetic Biology Technology and DNA Sequencing Landscape?
11. Medical Equipment Suppliers in Good Health - Research Report on Bruker Corporation, Agilent Technologies Inc., General Electric Company, Becton, Dickinson and Co. and Thermo Fisher Scientific Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... 19, 2017  SARES•REGIS Group leased the first ... at Conejo Spectrum Business Park in ... Biotherapeutics, Inc. , a biopharmaceutical company developing meaningful ... that have been underserved by scientific innovation, with ... cancer, autoimmune and infectious disease. Before ...
(Date:4/18/2017)... Research and Markets has announced the addition ... their offering. ... devices market to grow at a CAGR of 6.35% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... My T Chai, a South African company ... available for purchase on RevNutrition.com, a popular website specializing in sales of nutritional products. ... in ancient India and Siam. It spread across Asia and Africa quickly, and today ...
(Date:4/24/2017)... HOUSTON, TEXAS (PRWEB) , ... April 24, 2017 ... ... service (SaaS) based healthcare compliance and credentialing solutions, today announced that Kyle Allain ... Allain leads symplr’s Cactus Provider Management sales and operations, including provider, payor and ...
(Date:4/24/2017)... ... April 24, 2017 , ... In 2017, up to ... approximately 25,000 of them will be malignant.(1) As research into precision medicine continues, ... healthcare model in the diagnosis and treatment of brain tumors. Healthcare facilities that ...
(Date:4/24/2017)... , ... April 24, 2017 , ... Rod Burkett, CEO ... Housing News website. , Rod has been at the forefront of Gardant since it ... As CEO, Rod has overseen the opening of more than 40 new senior living ...
(Date:4/24/2017)... ... ... As a former supermodel known for her timeless beauty, Joan Severance knows ... is that she put all the words in her new book, "Manifest Your Mate: ... and sparkling sense of humor have inspired her to write a book on how ...
Breaking Medicine News(10 mins):